Elevated circulating follistatin associates with an increased risk of type 2 diabetes

Affiliations

• 1 Department of Clinical Sciences, Lund University, Malmö, Sweden.
• 2 School of Control Science and Engineering, Shandong University, Jinan, Shandong, China.
• 3 School of Intelligent Engineering, Shandong Management University, Jinan, Shandong, China.
• 4 Institute of Clinical Medicine, Internal Medicine, University of Eastern Finland, Kuopio, Finland.
• 5 A.I. Virtanen Institute for Molecular Sciences, Department of Biotechnology and Molecular Medicine, University of Eastern Finland, Kuopio, Finland.
• 6 Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA.
• 7 Department of Internal Medicine IV, Division of Endocrinology, Diabetology and Nephrology; and Department for Diagnostic Laboratory Medicine, Institute for Clinical Chemistry and Pathobiochemistry, University Hospital Tübingen, University of Tübingen, Tübingen, Germany.
• 8 Institute of Diabetes Research and Metabolic Diseases (IDM) of the Helmholtz Center Munich, Tübingen, Germany.
• 9 German Center for Diabetes Research (DZD), Tübingen, Germany.
• 10 Section of Experimental Radiology, Department of Radiology, University of Tübingen, Tübingen, Germany.
• 11 Division of Endocrinology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
• 12 Inserm U1283 / CNRS UMR 8199, European Genomic Institute for Diabetes (EGID), Institut Pasteur de Lille; University of Lille, Lille University Hospital, Lille, France.
• 13 Affinity Proteomics, Science for Life Laboratory, KTH Royal Institute of Technology, Stockholm, Sweden.
• 14 NIHR Exeter Clinical Research Facility, Royal Devon and Exeter Hospital and University of Exeter Medical School, Exeter, Devon, UK.
• 15 Division of Systems Medicine, University of Dundee, Ninewells Hospital & Medical School, Dundee, UK.
• 16 Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
• 17 Department of Cell Physiology and Metabolism, University Medical Centre, Geneva, Switzerland.
• 18 Department of Endocrinology and Metabolism, Division of Life Sciences of Medicine, University of Science and Technology of China, Hefei, China.
• 19 Division of Population Health & Genomics, School of Medicine, University of Dundee, Dundee, DD1 9SY, UK.
• 20 Steno Diabetes Center Copenhagen, Gentofte, Denmark.
• 21 Department of Medicine, Kuopio University Hospital, Kuopio, Finland.
• 22 Finnish Institute for Molecular Medicine, University of Helsinki, Helsinki, Finland.
• 23 Department of Clinical Sciences, Lund University, Malmö, Sweden. [email protected].
• 24 School of Control Science and Engineering, Shandong University, Jinan, Shandong, China. [email protected].
• 25 Department of Endocrinology and Metabolism, Division of Life Sciences of Medicine, University of Science and Technology of China, Hefei, China. [email protected].
• # Contributed equally.